Science · 3 September 2026 · From issue 32
(Un)intended consequences of mass-prescribing GLP-1s
Fair access to popular weight loss drugs faces threats from competing business interests.
Luc L. Hagenaars, Laura A. Schmidt.
Integrity screen: passed (3 checks) Checked 10 September 2026. Read the source
The plain-language reading of this paper is in the full issue, for subscribers.
Read the full issue